Tianjin Ringpu Bio Tech Total Liabilities
Tianjin Ringpu Bio Tech total liabilities. Based on the latest financial reports, Tianjin Ringpu Bio Tech (300119) has total liabilities worth CN¥2.53 Billion CNY (≈ $370.32 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Tianjin Ringpu Bio Tech asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Tianjin Ringpu Bio Tech (2007–2025)
Total liabilities of Tianjin Ringpu Bio Tech from 2007 to 2025. This chart illustrates how Tianjin Ringpu Bio Tech's total liabilities have evolved over time, based on quarterly financial data. Explore Tianjin Ringpu Bio Tech (300119) long-term investment share to see how much of total assets are deployed in long-term investments.
Tianjin Ringpu Bio Tech Competitors by Total Liabilities
The table below lists competitors of Tianjin Ringpu Bio Tech ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Qingdao Yunlu Advanced Materials Technology Co. Ltd. A
SHG:688190
|
China | CN¥719.01 Million |
|
Hunan Boyun New Materials Co Ltd
SHE:002297
|
China | CN¥970.26 Million |
|
TTW Public Company Limited
BK:TTW-R
|
Thailand | ฿4.11 Billion |
|
Flow Traders BV
AS:FLOW
|
Netherlands | €15.08 Billion |
|
JiLin Sino-Microelectronics Co Ltd
SHG:600360
|
China | CN¥2.15 Billion |
|
Goldsun Building Materials Co Ltd
TW:2504
|
Taiwan | NT$23.15 Billion |
|
NationGate Holdings Berhad
KLSE:0270
|
Malaysia | RM1.30 Billion |
|
Lotte Corp
KO:004990
|
Korea | ₩13.76 Trillion |
Liability Composition Analysis (2007–2025)
This chart breaks down Tianjin Ringpu Bio Tech's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Tianjin Ringpu Bio Tech (300119) total assets.
Liquidity & Leverage Metrics
Tianjin Ringpu Bio Tech Total Liabilities Ratios Explained
Tianjin Ringpu Bio Tech total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tianjin Ringpu Bio Tech's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tianjin Ringpu Bio Tech (2007–2025)
The table below shows the annual total liabilities of Tianjin Ringpu Bio Tech from 2007 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥2.47 Billion ≈ $361.63 Million |
-16.48% |
| 2024-12-31 | CN¥2.96 Billion ≈ $432.97 Million |
+65.20% |
| 2023-12-31 | CN¥1.79 Billion ≈ $262.09 Million |
+11.58% |
| 2022-12-31 | CN¥1.61 Billion ≈ $234.89 Million |
+17.41% |
| 2021-12-31 | CN¥1.37 Billion ≈ $200.05 Million |
+17.63% |
| 2020-12-31 | CN¥1.16 Billion ≈ $170.07 Million |
-3.64% |
| 2019-12-31 | CN¥1.21 Billion ≈ $176.50 Million |
+62.11% |
| 2018-12-31 | CN¥744.03 Million ≈ $108.88 Million |
-0.52% |
| 2017-12-31 | CN¥747.95 Million ≈ $109.45 Million |
+19.15% |
| 2016-12-31 | CN¥627.74 Million ≈ $91.86 Million |
+8.28% |
| 2015-12-31 | CN¥579.77 Million ≈ $84.84 Million |
+125.39% |
| 2014-12-31 | CN¥257.23 Million ≈ $37.64 Million |
-9.07% |
| 2013-12-31 | CN¥282.89 Million ≈ $41.40 Million |
+36.67% |
| 2012-12-31 | CN¥206.99 Million ≈ $30.29 Million |
+18.20% |
| 2011-12-31 | CN¥175.12 Million ≈ $25.63 Million |
-10.50% |
| 2010-12-31 | CN¥195.66 Million ≈ $28.63 Million |
+20.31% |
| 2009-12-31 | CN¥162.63 Million ≈ $23.80 Million |
+90.93% |
| 2008-12-31 | CN¥85.18 Million ≈ $12.46 Million |
+69.48% |
| 2007-12-31 | CN¥50.26 Million ≈ $7.35 Million |
-- |
About Tianjin Ringpu Bio Tech
Tianjin Ringpu Bio-Technology Co.,Ltd. engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products. The company provides vaccines, chemical drugs, traditional Chinese medicines; feed additives, including pigs, chickens, waterfowl, cattle, sheep and pet medicines, and vaccines; and p… Read more